Published in Cancer Weekly, November 1st, 2005
Study 1: Donor cell allodepletion may reduce the rate of severe acute graft-versus-host disease in older patients.
"We report a clinical trial to decrease graft-versus-host disease (GVHD) in elderly patients receiving selectively depleted PBSC transplants from HLA-identical sibling donors," scientists writing in the journal Blood report.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly